Elanco Animal Health (ELAN) Q1 2024 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Furthering its mission to bring regenerative medicine to all pets, animal biotech company Gallant Therapeutics welcomes an industry leader, Dr. Val Williams,.
Kindred Bio: Q4 Earnings Snapshot
March 16, 2021
FacebookTwitterEmail
BURLINGAME, Calif. (AP) Kindred Biosciences Inc. (KIN) on Tuesday reported a loss of $10.9 million in its fourth quarter.
The Burlingame, California-based company said it had a loss of 28 cents per share.
The biopharmaceutical company posted revenue of $951,000 in the period.
For the year, the company reported that its loss narrowed to $21.8 million, or 55 cents per share. Revenue was reported as $42.2 million.
In the final minutes of trading on Tuesday, the company s shares hit $4.94. A year ago, they were trading at $6.01.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN
Kindred Biosciences (NASDAQ:KIN), (ELAN) - Kindred Biosciences Submits Efficacy Data For KIND-030 As Prophylactic Option In US benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.